Project Grant R21AI199501
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a Project Grant totaling $1,731,364 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 29, 2025, with a completion date of July 31, 2029. This biomedical research grant supports investigator-initiated scientific research examining the mechanisms by which microglial interferon-gamma (IFN-γ) production functions as a...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $847,000 in Project Grant funding to The University of Kentucky Research Foundation on July 15, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research, scheduled for completion by June 30, 2027, focuses on identifying the protective roles of CD180 and nucleotide oligomerization domain 1 (NOD1)—two pathogen-associated molecular pattern...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a $181,103 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a three-year research initiative spanning June 1, 2026, through May 31, 2029. This research project delivers mechanistic and transcriptomic modeling studies comparing the therapeutic efficacy of aztreonam/avibactam (ATM/AVI) versus aztreonam...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a $420,063 Project Grant on February 18, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to fund research investigating the molecular mechanisms controlling bacteriophage lysis in Borrelia burgdorferi, the spirochete responsible for Lyme disease. The Stevenson Lab will identify and functionally characterize...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a Project Grant totaling $423,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 1, 2025, through June 30, 2027. This research project investigates the functional roles of chlamydial polymorphic membrane proteins (PMPs), specifically PMPI, during the infectious cycle of Chlamydia trachomatis. The...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Virginia $795,990 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year research project spanning April 23, 2026 through March 31, 2031. The project, titled "Targeting Resistance at Its Source: Identifying Superspreaders of Antimicrobial Resistance Genes in Hospital Ecosystems," delivers advanced research services...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Massachusetts a $412,581 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2027. This research initiative focuses on investigating specialized mitochondrial deoxyribonucleic acid (DNA) polymerases in African trypanosomes to advance understanding of kinetoplast DNA (kDNA) replication mechanisms....
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Arkansas for Medical Sciences $420,335 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 23, 2025, for a project period extending through May 31, 2027. The project investigates the role of lytic viral genes in the pathogenesis of oncogenic gammaherpesviruses, specifically examining whether lytic gene expression drives the development and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $777,360 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This award funds research titled "Advancing Lymphatic Filariasis Elimination with Parasite Genomic Epidemiology," which will deliver comprehensive genomic analysis and characterization of Wuchereria bancrofti...
- Federal Grant Award Summary Indiana University, serving as the prime grantee, received a $237,750 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 24, 2025. The grant supports a research project examining the health and environmental impacts of a citywide sanitation infrastructure intervention in Indianapolis, Indiana, with a performance period extending through June 30,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a $184,592 Project Grant on May 22, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate microbial contamination and persistence in flood-affected building materials. The research will be conducted in Lexington, Kentucky, with a completion date of April 30, 2028. The project combines field-based floodwater sampling from diverse urban and rural locations in Kentucky with controlled mesocosm experiments to track microbial colonization on common building materials including concrete, drywall, insulation, and wood. The deliverables include shotgun metagenomic sequencing analysis identifying pathogens, antibiotic resistance genes, virulence factors, and biofilm traits; comparative assessment of microbial viability and persistence using both metagenomics and culture-based assays; whole-genome sequencing and comparative genomics of selected isolates; and exposure modeling data to inform public health and remediation strategies. The research produces a comprehensive genome-resolved evaluation of microbial behavior in flood-impacted indoor environments to address the critical public health gap regarding long-term microbial risks in porous building materials. Study findings will identify overlooked microbial threats and generate actionable data to support evidence-based exposure assessment and public health decision-making for flood remediation and building safety protocols.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $184.6k | 5/26/26 |